Literature DB >> 8157646

A peptide encoding the c-Jun delta domain inhibits the activity of a c-jun amino-terminal protein kinase.

V Adler1, T Unlap, A S Kraft.   

Abstract

Evidence suggests that the c-Jun protooncogene delta (delta) domain (amino acids 31-60) helps regulate the transcriptional activating capacity of c-Jun by modulating the amino-terminal phosphorylation of this protein. By using a peptide encoding the delta domain and purified amino-terminal c-Jun protein kinase, we demonstrate that the delta domain peptide inhibits phosphorylation of the amino terminus of both c-Jun and the related protein JunD. The delta domain peptide inhibited the activation of the c-Jun amino-terminal protein kinase by phorbol esters in permeabilized U937 leukemic cells. Mutation of c-Jun followed by transfection into U937 leukemic cells demonstrated that partial deletions of the delta domain are sufficient to block phosphorylation of the amino terminus of c-Jun. In vitro deletion of the amino-terminal (amino acids 31-44) half of the delta domain inhibited the phosphorylation of c-Jun. However, deletion of the carboxyl-terminal (amino acids 45-60) half only partially inhibited c-Jun phosphorylation. Therefore, these results indicate that the delta domain sequence is an important regulator of c-Jun amino-terminal phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157646

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

2.  Selective interaction of JNK protein kinase isoforms with transcription factors.

Authors:  S Gupta; T Barrett; A J Whitmarsh; J Cavanagh; H K Sluss; B Dérijard; R J Davis
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

3.  Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase.

Authors:  D Jacobs; D Glossip; H Xing; A J Muslin; K Kornfeld
Journal:  Genes Dev       Date:  1999-01-15       Impact factor: 11.361

4.  MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway.

Authors:  J Raingeaud; A J Whitmarsh; T Barrett; B Dérijard; R J Davis
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

5.  Engineered Substrate-Specific Delta PKC Antagonists to Enhance Cardiac Therapeutics.

Authors:  Nir Qvit; Opher S Kornfeld; Daria Mochly-Rosen
Journal:  Angew Chem Int Ed Engl       Date:  2016-11-17       Impact factor: 15.336

6.  Signal transduction by tumor necrosis factor mediated by JNK protein kinases.

Authors:  H K Sluss; T Barrett; B Dérijard; R J Davis
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

7.  Complexes of p21RAS with JUN N-terminal kinase and JUN proteins.

Authors:  V Adler; M R Pincus; P W Brandt-Rauf; Z Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

Review 8.  Multiple facets of junD gene expression are atypical among AP-1 family members.

Authors:  J M Hernandez; D H Floyd; K N Weilbaecher; P L Green; K Boris-Lawrie
Journal:  Oncogene       Date:  2008-04-21       Impact factor: 9.867

9.  Targeted disruption of the K-ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysis.

Authors:  H Allgayer; H Wang; S Shirasawa; T Sasazuki; D Boyd
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.